These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Urinary excretion of unmetabolized and phase II conjugates of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans: relationship to cytochrome P4501A2 and N-acetyltransferase activity. Stillwell WG, Kidd LC, Wishnok JS, Tannenbaum SR, Sinha R. Cancer Res; 1997 Aug 15; 57(16):3457-64. PubMed ID: 9270013 [Abstract] [Full Text] [Related]
4. Intra- and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl- 6-phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef. Lynch AM, Knize MG, Boobis AR, Gooderham NJ, Davies DS, Murray S. Cancer Res; 1992 Nov 15; 52(22):6216-23. PubMed ID: 1423264 [Abstract] [Full Text] [Related]
5. Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans. Turesky RJ, Garner RC, Welti DH, Richoz J, Leveson SH, Dingley KH, Turteltaub KW, Fay LB. Chem Res Toxicol; 1998 Mar 15; 11(3):217-25. PubMed ID: 9544620 [Abstract] [Full Text] [Related]